Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Primary Results From the Multicenter, Randomized, Phase 2 DESTINY-CRC02 Study - T-DXd in Patients With HER2+ mCRC"

67 views
July 11, 2023
Comments 0
Login to view comments. Click here to Login